Track market-moving stories before they get noisy

On June 17, 2026, A.O. Smith Corp AOS shares fell by 3.9%, bringing the current price to $57.88. The stock has traded within a 52-week range of $54.16 to $81.87, reflecting volatility in the market. The recent decline adds to a year-to-date loss of 12.5%.

GF Value™ verdict: Current price at $57.88 is 24.6% below GF Value™ of $76.73.GF Score™ of 86/100 indicates a strong overall performance.Most notable signal: Financial Strength rated at 8/10, suggesting robust financial stability. Is AOS Overvalued or Undervalued? A.O. Smith Corp is currently priced at $57.88, which is significantly lower than the GF Value™ estimate of $76.73, marking the stock as 24.6% undervalued. This discrepancy indicates a potential opportunity for value-oriented investors, as the current pricing offers a margin of safety. The GF Valuation label characterizes the stock as modestly undervalued, suggesting that the price may not fully reflect the company's intrinsic value based on its historical performance and future expectations.

GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. While the undervaluation presents an opportunity, it is essential to consider market risks and economic conditions that could impact stock performance moving forward.

How Does AOS's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 15.4x 20.7x Forward P/E 15.4x N/A A.O. Smith Corp's current P/E ratio of 15.4x is significantly lower than its 5-year median P/E of 20.7x, indicating that the stock is trading below its historical valuation. This analysis agrees with the GF Value™ verdict that A.O. Smith is undervalued, supporting the notion that the stock may provide a good entry point based on historical earnings multiples.

What Does AOS's GF Score™ Tell Us? Metric Rating GF Score™ 86/100 Financial Strength 8/10 Profitability 9/10 Growth 7/10 Valuation 8/10 Momentum 4/10 The GF Score™ of 86/100 reveals a strong overall performance, particularly in Profitability, which is rated at a high 9/10. This suggests that A.O. Smith Corp maintains a healthy profit margin and efficient operations. The Financial Strength score of 8/10 further underscores the company's solid balance sheet and operational stability. However, the Momentum rank of 4/10 indicates that the stock has faced recent challenges in maintaining upward price trends, which may necessitate careful consideration by potential investors.

What Are Insiders Doing with AOS Stock? According to the latest data, there have been no insider transactions in the last three months for A.O. Smith Corp. This lack of insider activity may suggest that company executives and board members currently do not see immediate opportunities to buy or sell shares, which could indicate a stable outlook from their perspective, but it also leaves open the question of confidence in the stock's future performance.

What This Means for Investors Based on the GF Value™ assessment, A.O. Smith Corp is currently undervalued at a price of $57.88 compared to a GF Value™ of $76.73. This valuation presents a potential opportunity for investors, although it is essential to remain aware of market volatility and other external factors that might influence future stock performance.

For the complete analysis, visit the A.O. Smith Corp AOS stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is AOS's GF Score™?

A.O. Smith Corp has a GF Score™ of 86/100, indicating a strong overall performance and potential for higher long-term returns.

Is AOS overvalued or undervalued?

A.O. Smith Corp is currently undervalued, with a GF Value™ of $76.73 compared to the current price of $57.88.

What is AOS's P/E ratio?

A.O. Smith Corp has a current P/E (TTM) of 15.4x, which is significantly below its 5-year median P/E of 20.7x, indicating a more attractive valuation compared to historical levels.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

MILWAUKEE, June 22, 2026 /PRNewswire/ -- A. O. Smith Corporation (NYSE: AOS), a global leader in water technology, announced today that Executive Chairman Kevin Wheeler will retire effective July 1.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.

In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.

One company to watch right now is Archer Daniels Midland (ADM - Free Report) . ADM is currently sporting a Zacks Rank #2 (Buy), as well as an A grade for Value. The stock holds a P/E ratio of 13.41, while its industry has an average P/E of 14.90. Over the past 52 weeks, ADM's Forward P/E has been as high as 14.13 and as low as 9.50, with a median of 11.12.

Value investors also frequently use the P/S ratio. This metric is found by dividing a stock's price with the company's revenue. Some people prefer this metric because sales are harder to manipulate on an income statement. This means it could be a truer performance indicator. ADM has a P/S ratio of 0.45. This compares to its industry's average P/S of 0.81.

Finally, investors should note that ADM has a P/CF ratio of 13.25. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. This company's current P/CF looks solid when compared to its industry's average P/CF of 14.30. Over the past 52 weeks, ADM's P/CF has been as high as 13.80 and as low as 7.44, with a median of 9.16.

These are only a few of the key metrics included in Archer Daniels Midland's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, ADM looks like an impressive value stock at the moment.

Powered by the new RADCOM RASE real-time, adaptive streaming engine, RADCOM ADM cuts analytics changes from months-long projects to same-day deployment

, /PRNewswire/ -- RADCOM Ltd. (NASDAQ: RDCM) announced today the introduction of RADCOM ADM (Analytics Designer Module), a new module of the RADCOM ACE platform. It enables network data analysts to define, configure, and deploy datasets, KPIs (key performance indicators), and alarms in real time without requiring vendor engagement, software release cycles, and service interruption, reducing change cycles from months to the same day and meeting the pace and scale of the world's leading telecom networks.

As network automation and agentic systems take hold, traditional analytics impose three constraints on operator agility. They are not dynamic: changes to data structures often require vendor engagement, a new software release, and a planned service interruption. They are not cost-efficient: simple requests can turn into months-long custom development projects. And they are not real-time: analytics often run at 15-minute resolution at best, while live troubleshooting needs sub-one-minute granularity, down to 10 seconds. RADCOM ADM is designed to address all three. It draws on both RADCOM ACE assurance data and external feeds, real-time or historical, with on-the-fly Call Detail Record (CDR) correlation.

"The pace at which network conditions change demands analytics that can keep up," said Eran Dotan Rosenberg, Vice President of Product Management at RADCOM. "With RADCOM ADM, operators can define the data they need, at the resolution they need it, and the moment they need it. The platform adapts to the operator, not the other way around. And because streaming data flows directly into RADCOM Neura's agentic AI layer, ADM serves as the data foundation that makes Neura's agents reliable and accurate, turning real-time insights into automated action."

The module is powered by RADCOM RASE (Real-time Adaptive Streaming Engine), RADCOM's new real-time analytics engine, which combines dynamic aggregation with resolution as fine as 10 seconds. Critically, it surfaces insights into the subscriber's experience as events unfold. Delivering RADCOM RASE required a fundamental rebuild of RADCOM's core infrastructure, including new in-memory databases, a new processing architecture, and new scaling approaches. This is the depth of engineering required to deliver real-time analytics at Tier-1 operator scale, and it is not easily replicated.

The result is a shared analytics foundation across RADCOM ACE: every KPI defined in RADCOM ADM flows into RADCOM ACE network analytics, RADCOM AIM anomaly detection, and RADCOM Neura's agentic AI layer, using the same KPI identifier to establish a single source of truth across the platform.

For operators, RADCOM ADM is designed to help teams that depend on network data get what they need in real time: network operations teams that need immediate, on-demand data for fault resolution; network planners and engineers that need structured planning data; and business functions such as marketing, fraud management, and device analytics that need business intelligence (BI)-grade reporting. Behind this, RADCOM ADM gives the network data analyst an Integrated Development Environment (IDE)-like workspace to define and deploy datasets, KPIs, and alarms, which each team can then access directly with appropriate permissions.

RADCOM ADM will be generally available to RADCOM ACE customers in the third quarter of 2026 as a licensed module of the RADCOM ACE platform.

For all investor inquiries, please contact:

Investor Relations:
Rob Fink or Joey Delahoussaye
FNK IR
[email protected]
646-809-4048 / 312-809-1087

Company Contact:
Hod Cohen
CFO
+972-3-645-5055
[email protected]

About RADCOM

RADCOM (NASDAQ: RDCM) is a leading provider of advanced, intelligent assurance solutions with integrated AI Operations (AIOps) capabilities. Its flagship platform, RADCOM ACE, harnesses AI-driven analytics and generative AI (GenAI) to improve customer experiences. From lab testing to full-scale deployment, RADCOM utilizes cutting-edge networking technologies to capture and analyze real-time data. Its advanced 5G portfolio delivers end-to-end network observability, from the radio access network (RAN) to the core.

Designed to be open, vendor-neutral, and cloud-agnostic, RADCOM's solutions drive next-generation network automation, optimization, and efficiency. By leveraging AI-powered intelligence, RADCOM reduces operational costs, enables predictive customer insights, and seamlessly integrates with business support systems (BSS), operations support systems (OSS), and service management platforms. Offering a complete, real-time view of mobile and fixed networks, RADCOM empowers telecom operators to ensure exceptional service quality, enhance user experiences, and build customer-centric networks.

Risks Regarding Forward-Looking Statements

Certain statements made herein that use words such as "estimate," "project," "intend," "expect," "believe," "may," "might," "potential," "anticipate," "plan," "designed to," "will," or similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. For example, when the Company discusses the introduction, capabilities, performance, scalability, reliability, accuracy, interoperability, and anticipated benefits of RADCOM ADM, RADCOM RASE, RADCOM ACE, RADCOM AIM, and RADCOM Neura; the ability of RADCOM ADM and RADCOM RASE to perform as expected; and the anticipated value of these innovations to installed and new customers and the timing of the expected general availability of RADCOM ADM, it is using forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties that could cause the actual results, performance, or achievements of the Company to be materially different from those that may be expressed or implied by such statements, including, among others, changes in general economic and business conditions and specifically, decline in demand for the Company's products, inability to timely develop and introduce new technologies, products, and applications, loss of market share and pressure on prices resulting from competition and the effects of the conflict in Israel. For additional information regarding these and other risks and uncertainties associated with the Company's business, reference is made to the Company's reports filed from time to time with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to revise or update any forward-looking statements, except as required by law.

SOURCE RADCOM Ltd.

Booking Holdings (BKNG - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Over the past month, shares of this online booking service have returned +9.4%, compared to the Zacks S&P 500 composite's +0.3% change. During this period, the Zacks Internet - Commerce industry, which Booking Holdings falls in, has lost 9.5%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Booking Holdings is expected to post earnings of $2.47 per share for the current quarter, representing a year-over-year change of +11.3%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

The consensus earnings estimate of $10.44 for the current fiscal year indicates a year-over-year change of +14.5%. This estimate has remained unchanged over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $12.35 indicates a change of +18.3% from what Booking Holdings is expected to report a year ago. Over the past month, the estimate has remained unchanged.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Booking Holdings.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Booking Holdings, the consensus sales estimate of $7.19 billion for the current quarter points to a year-over-year change of +5.7%. The $29.4 billion and $32.08 billion estimates for the current and next fiscal years indicate changes of +9.2% and +9.1%, respectively.

Last Reported Results and Surprise HistoryBooking Holdings reported revenues of $5.53 billion in the last reported quarter, representing a year-over-year change of +16.2%. EPS of $1.14 for the same period compares with $0.99 a year ago.

Compared to the Zacks Consensus Estimate of $5.5 billion, the reported revenues represent a surprise of +0.61%. The EPS surprise was +3.64%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Booking Holdings is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Booking Holdings. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Store

SubscribeSign In

My Subscriptions

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveCustomer Center

My Stock Lists

Email Preferences

Help & Support

Sign Out

Search stocks or keywords

Sections

My IBD

MARKET TREND

STOCK LISTS

STOCK RESEARCH

NEWSECONOMY

VIDEOS & PODCASTS

HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live

Recently Searched

Chip Equipment Maker KLA Hits Record High, Leads 16 Stars Onto Best Stock Lists

AI Stock Market Leaders Thumped As SpaceX Takes Traders On Wild Ride; Three Strong Sell Rules To Use Now

Google-Parent Alphabet To Join Dow Jones Industrial Average, Replacing Verizon Cruise lines skidded Tuesday after Carnival (CCL) missed revenue views and cut parts of its outlook. River cruise operator Viking Holdings (VIK) extended its record highs, while Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH) rose modestly. Carnival (CCL) reported a 15% increase in adjusted earnings to 41 cents per share, despite taking a hit of 6 cents per share…

Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

SAO PAULO, June 23, 2026 (GLOBE NEWSWIRE) -- KAYAK surveyed 2,000 travellers to find out which football player they'd most want to travel with, and where in Brazil they'd take them.

Passport stamped for the Portuguese star

Cristiano Ronaldo was chosen by 60% of respondents, followed by Vinícius Júnior (19%) and Endrick (9%). The reasons? 41% cited personal admiration, 23% want to see what goes on behind the scenes of an athlete's holiday, and 15% want to live a once in a lifetime experience alongside one of football's biggest names.

The Northeast Steals the Show

When asked where they'd take their football idol, 59% of Brazilians pointed to the Northeast region of the country, with destinations like Bahia. Another 17% would go for the South, with cities like Gramado.

From the month of football to the next trip

Cristiano Ronaldo was born in Funchal, Madeira, accessible from Brazil via Lisbon. Fans can explore where he grew up and stay at the Pestana CR7 hotel. Round-trip flights to Lisbon between July and December average R$5,296.

Planning your trip? Use Ask AI on KAYAK for real-time results on flights, hotels, and car rentals.

Methodology

Research Insights

KAYAK conducted an online survey with The Ripple Effect among 2,000 adults (18+) in Brazil who had traveled for leisure within or outside the country in the last 1-2 years and who also intend to travel in the next 12 months. Fieldwork was conducted between May 15 and 18, 2026.

Flights data

Based on flight searches conducted on KAYAK.com.br and associated brands between January 1, 2026 and June 10, 2026 for flights between July 1, 2026 and December 31, 2026 departing from any Brazilian airport. All prices are averages for round-trip tickets in economy class, may vary, and cannot be guaranteed.

About KAYAK

KAYAK, part of Booking Holdings (NASDAQ: BKNG), is the world's leading travel search engine. With billions of searches on our platforms, we help people find their perfect flight, accommodation, car rental, and holiday package. We also support business travellers with

our corporate travel solution.

Media contact:

[email protected]

New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-counter products to help manage common side effects available to support patients 

MinuteClinic® expands virtual care with new weight management offering and $49 visits

, /PRNewswire/ -- As demand for GLP-1 medications continues to increase across the U.S., CVS Health® (NYSE: CVS) today announced a comprehensive approach to GLP-1 support spanning its more than 9,000 CVS Pharmacy® locations and MinuteClinic®, available virtually in nearly all states. New offerings include expanded pharmacy support designed to help patients access these treatments and stay on them, and a new $49 MinuteClinic virtual visit that connects eligible adults with licensed clinicians who can evaluate and, where clinically appropriate, prescribe GLP-1 therapy.

CVS pharmacist consulting with patient. The new approach combines lower-cost access, personalized pharmacist support, and over-the-counter products to help manage common side effects, which are three of the biggest barriers patients face when starting GLP‑1 therapy.

CVS Pharmacy offers a broad range of GLP‑1 prescription medications, including both injectable and oral options from multiple manufacturers, along with new digital resources available on CVS.com. Together with guidance from trusted neighborhood pharmacists, these tools are designed to support patients from their first dose through ongoing treatment.

"Access is only part of the equation with GLP‑1 medications. Patients also need support to stay on therapy and see results," said Sid Tenneti, Senior Vice President and Interim President, Pharmacy and Consumer Wellness. "From helping patients manage side effects to identifying ways to lower costs, our pharmacists are there every step of the way."

Lower cost access to GLP-1 medications

To help address cost concerns, CVS Pharmacy will begin participating in the Centers for Medicare & Medicaid Services (CMS) Medicare GLP‑1 Bridge program starting July 1, 2026. Through the program, which runs through December 31, 2027, eligible Medicare beneficiaries can access certain GLP‑1 medications for $50 per month, offering more predictable and affordable pricing for patients who qualify.

For those not eligible, CVS Pharmacy accepts a wide range of third-party prescription discount cards, manufacturer coupons, and manufacturer vouchers to help reduce out-of-pocket costs. At CVS Pharmacy, the out-of-pocket cost for a GLP-1 medication can be as low as $25 a month through commercial insurance with a manufacturer coupon for eligible patients, or $149 for those without insurance who utilize a manufacturer voucher for qualifying medications and doses. CVS Pharmacy is a retail pharmacy partner for NovoCare®, a program that offers discounted Wegovy® and Ozempic®, and was the first to build a streamlined NovoCare enrollment experience.

Pharmacists at the center of care

As more patients turn to GLP‑1 medications, CVS Pharmacy is emphasizing the role of its pharmacists in helping patients navigate treatment.

According to the CVS Health 2025 Rx Report, nearly half of consumers prioritize personalized care at the pharmacy, and many prefer in-person pharmacy support over digital-only options - highlighting the ongoing importance of face-to-face interactions with pharmacists. From answering questions about dosing to helping patients manage side effects and stay on track, CVS pharmacists play a critical role in supporting the overall treatment experience and are available when it is convenient for the patient.

Clinical weight loss support available at MinuteClinic

MinuteClinic is broadening its virtual care platform with the launch of a new digital health offering that connects eligible adults with licensed clinicians to evaluate their weight loss and metabolic health needs and, where clinically appropriate, prescribe FDA-approved GLP-1 medications for weight loss.

At $49 per visit with no recurring membership or monthly fee, the program is built to make a first step toward weight management straightforward and affordable. Patients begin with a virtual video visit with a licensed physician associate or nurse practitioner, who reviews their health history and weight-management goals before determining whether a GLP-1 therapy is the right fit. Those who start treatment can schedule follow-up visits as needed for dose adjustments, side-effect support, and ongoing monitoring.

The program is available in 47 states and Washington, D.C., and is designed for self-pay adults ages 18 to 64 who are overweight or living with obesity and intend to pay out of pocket for clinical weight loss services. Patients seeking weight loss or metabolic health clinical support can visit MinuteClinic.com.

Over-the-counter products to help manage side effects

Side effects remain one of the leading reasons patients discontinue GLP‑1 therapy. To help address this, CVS Pharmacy has expanded its product assortment and is highlighting CVS brand and national brand over-the-counter products to help make managing side effects easier. Pharmacists can discuss concerns and help manage side effects in collaboration with prescribers.

In select locations, dedicated product displays highlight items that can help manage common issues such as nausea and gastrointestinal discomfort, as well as products that support hydration, protein intake, and overall nutrition. These in-store curated displays, sponsored by Haleon, are designed to bring together pharmacist guidance and practical, easy-to-find products to make it simpler for patients to manage their treatment. 

Customers can also select from a wide array of CVS brand products found throughout the store to help manage common GLP-1 side effects that offer the quality and value customers have come to expect from CVS Pharmacy store brands.

For more information on CVS Pharmacy's GLP‑1 support offerings, visit www.CVS.com/GLP1.

*For weight loss-related consultation only. Does not include the price of laboratory tests required.

About CVS Health
CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 88 million plan members. The Company also serves an estimated more than 37 million people through a broad range of health insurance products and related services. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Media contact
Amy Thibault
401-318-2865
[email protected]

SOURCE CVS Health

CVS Health (CVS +0.27%) is pushing harder into a hot segment of the pharmacy market, and on Monday investors rewarded the company for the effort. The pharmacy retailer's stock rose 3% on the news, contrasting very favorably with the slight (0.2%) decline of the bellwether S&P 500 index.

Weight loss equals business gain That morning, before market open, CVS announced it is expanding support for GLP-1 weight-loss medications across its many U.S. pharmacies and MinuteClinics.

Image source: Getty Images.

This includes more pharmacy support to improve access to such medications for patients and help them maintain their regimens. CVS added that it has introduced a new specialty MinuteClinic virtual visit offering focused on GLP-1 prescription and administration, priced at $49 per visit.

More importantly, on July 1, CVS will begin participating in the Centers for Medicare & Medicaid Services' (CMS) Medicare GLP-1 Bridge Program, a federal discount initiative.

In the press release touting the new offerings, CVS quoted its interim president of pharmacy and consumer wellness, Sid Tenneti, as saying that "Access is only part of the equation with GLP‑1 medications. Patients also need support to stay on therapy and see results."

Today's Change

(

0.27

%) $

0.27

Current Price

$

101.57

Getting them to the pharmacy counter American consumers can't get enough of obesity medications, so CVS is right to bulk up its GLP-1 services. I feel that the Bridge program discount will be a particularly attractive draw for qualifying patients, and overall, this expansion will provide a lift to CVS's business. Just now, this company looks like one of the best -- if not the best -- U.S. pharmacy stock.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: CVS Health (CVS - Free Report) Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a health solutions company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader healthcare commitment. In 2018, CVS Health acquired insurance giant Aetna for $70-billion.

CVS is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.

It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 13.62; value investors should take notice.

12 analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.30 to $7.44 per share. CVS boasts an average earnings surprise of +16.8%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, CVS should be on investors' short list.

Deciding between Vanguard Global ex-U.S. Real Estate ETF (VNQI 0.96%) and State Street SPDR Dow Jones REIT ETF (RWR +1.31%) depends on whether an investor seeks broad international diversification or concentrated U.S. exposure.

Both funds provide liquid access to real estate, yet they operate in entirely different geographic spheres. While VNQI casts a wide net across more than 30 countries to capture global growth, RWR remains strictly focused on the domestic market through the Dow Jones U.S. Select REIT Capped Index.

Snapshot (cost & size)MetricVNQIRWRIssuerVanguardSPDRExpense ratio0.12%0.25%1-yr return (as of June 17, 2026)1.6%14.6%Dividend yield4.7%3.3%Beta0.921.01AUM~$3.8 billion~$1.9 billionBeta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

The Vanguard fund is the more affordable choice, charging an expense ratio of 0.12% compared to 0.25% for the SPDR ETF. For income-seeking investors, the Vanguard fund also provided a higher dividend payout over the trailing 12 months.

Performance & risk comparisonMetricVNQIRWRMax drawdown (5 yr)(35.60%)(32.60%)Growth of $1,000 over 5 years (total return)$927$1,251What's insideThe SPDR ETF holds 99 positions primarily focused on U.S. real estate investment trusts (REITs). Its largest positions include Prologis (PLD +0.99%) at 10.09%, Welltower (WELL +2.94%) at 9.46%, and Simon Property Group (SPG +1.01%) at 4.7%. The fund was launched in 2001 and paid $3.73 per share in dividends over the trailing 12 months.

By contrast, Vanguard’s fund offers much broader diversification, with 708 holdings across international markets. Its largest positions include Goodman Group (GMG +0.89%) at 4.24%, Mitsubishi Estate at 2.81%, and Mitsui Fudosan at 2.43%. VNQI was launched in 2010 and has a trailing-12-month dividend payout of $2.16 per share.

For more guidance on ETF investing, check out the full guide at this link.

What this means for investorsThese real estate-focused ETFs are most obviously differentiated by the geographies they invest in and their number of holdings. Vanguard's fund holds seven times as many stocks as RWR and excludes U.S. companies. RWR is about half the size of VNQI in terms of assets under management, but they share roughly equal average trading volume.

One thing that stands out is just two stocks -- Prologis and Welltower -- account for nearly 20% of the SPDR ETF's holdings. In contrast, VNQI's top 10 positions make up 21.7% of the portfolio. So there's a real contrast in terms of diversification and concentration risk. That said, RWR has performed better recently, though it also has a higher expense ratio and lower dividend yield. But as investors know, a stock's price and its dividend yield have an inverse relationship, all things equal. So when the price goes up, the yield falls.

In my opinion, the whole point of buying an ETF is that you're getting a basket of stocks to help lower your overall risk. I wouldn't necessarily buy VNQI, but RWR's two largest positions making up around one-fifth of the portfolio isn't my cup of tea.

Erin Kennedy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Goodman Group, Prologis, and Simon Property Group. The Motley Fool has a disclosure policy.

Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Prologis (PLD - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.

Prologis is one of 831 companies in the Finance group. The Finance group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Prologis is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for PLD's full-year earnings has moved 0.7% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Based on the latest available data, PLD has gained about 10.1% so far this year. Meanwhile, the Finance sector has returned an average of 3.6% on a year-to-date basis. This shows that Prologis is outperforming its peers so far this year.

Another Finance stock, which has outperformed the sector so far this year, is Atlanticus Holdings Corporation (ATLC - Free Report) . The stock has returned 49.5% year-to-date.

In Atlanticus Holdings Corporation's case, the consensus EPS estimate for the current year increased 11.8% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

To break things down more, Prologis belongs to the REIT and Equity Trust - Other industry, a group that includes 90 individual companies and currently sits at #72 in the Zacks Industry Rank. On average, this group has gained an average of 10% so far this year, meaning that PLD is performing better in terms of year-to-date returns.

In contrast, Atlanticus Holdings Corporation falls under the Financial - Miscellaneous Services industry. Currently, this industry has 107 stocks and is ranked #106. Since the beginning of the year, the industry has moved -6.5%.

Prologis and Atlanticus Holdings Corporation could continue their solid performance, so investors interested in Finance stocks should continue to pay close attention to these stocks.

, /PRNewswire/ -- FIBRA Prologis (BMV: FIBRAPL 14), a leading owner and operator of Class-A logistics real estate in Mexico, will host a webcast and conference call with senior management to discuss second quarter results, current market conditions and future outlook on Friday, July 24, at 9:00 a.m. Mexico Time.

To access a live broadcast of the call, dial +1 888 596 4144 (toll-free from the United States and Canada), 800 269 4416 (toll-free from Mexico) or +1 646 968 2525 from all other countries or and enter conference code 4603995. A live webcast can be accessed at www.fibraprologis.com in the Investor Relations section July 24.

A telephonic replay will be available July 24 – July 31 at +1 800 770 2030 from the U.S. and Canada or at +1 647 362 9199 from all other countries using conference code 4603995. The replay will be posted in the Investor Relations section of the FIBRA Prologis website.

ABOUT FIBRA PROLOGIS

FIBRA Prologis is a leading owner and operator of Class-A industrial real estate in Mexico. As of March 31, 2026, the company's portfolio comprised 516 Investment Properties, totaling 86.9 million square feet (8.1 million square meters). This includes 350 logistics and manufacturing facilities across 6 industrial core markets in Mexico, comprising 65.8 million square feet (6.1 million square meters) of Gross Leasing Area (GLA) and 166 buildings with 21.1 million square feet (1.9 million square meters) of non-strategic assets in other markets.

FORWARD-LOOKING STATEMENTS

The statements in this release that are not historical facts are forward-looking statements. These forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which FIBRA Prologis operates, management's beliefs and assumptions made by management.  Such statements involve uncertainties that could significantly impact FIBRA Prologis financial results. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature.  All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to rent and occupancy growth, acquisition activity, development activity, disposition activity, general conditions in the geographic areas where we operate, our debt and financial position, are forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. Some of the factors that may affect outcomes and results include, but are not limited to: (i) national, international, regional and local economic climates, (ii) changes in financial markets, interest rates and foreign currency exchange rates, (iii) increased or unanticipated competition for our properties, (iv) risks associated with acquisitions, dispositions and development of properties, (v) maintenance of real estate investment trust ("FIBRA") status and tax structuring, (vi) availability of financing and capital, the levels of debt that we maintain and our credit ratings, (vii) risks related to our investments (viii) environmental uncertainties, including risks of natural disasters, (ix) risks related to the coronavirus pandemic, and (x) those additional factors discussed in reports filed with the "Comisión Nacional Bancaria y de Valores" and  the Mexican Stock Exchange by FIBRA Prologis under the heading "Risk Factors." FIBRA Prologis undertakes no duty to update any forward-looking statements appearing in this release.

Non-Solicitation - Any securities discussed herein or in the accompanying presentations, if any, have not been registered under the Securities Act of 1933 or the securities laws of any state and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act and any applicable state securities laws. Any such announcement does not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein or in the presentations, if and as applicable.

SOURCE FIBRA Prologis

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Prologis (PLD - Free Report) .

Prologis currently has an average brokerage recommendation (ABR) of 1.92, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 24 brokerage firms. An ABR of 1.92 approximates between Strong Buy and Buy.

Of the 24 recommendations that derive the current ABR, 13 are Strong Buy, representing 54.2% of all recommendations.

Brokerage Recommendation Trends for PLD

Check price target & stock forecast for Prologis here>>>

The ABR suggests buying Prologis, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Is PLD Worth Investing In?Looking at the earnings estimate revisions for Prologis, the Zacks Consensus Estimate for the current year has increased 0.1% over the past month to $6.18.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Prologis. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Prologis may serve as a useful guide for investors.

The world's largest owner of industrial real estate said it sees a clear strategic rationale for a combination and urged Segro shareholders to encourage the board to engage.

Key Takeaways ARE rose 10.9% over the past month, outpacing the industry's 2.4% gain.ARE leased 647,356 RSF in Q1 2026; 72% came from existing tenants, reflecting tenant retention.ARE expects $92M in incremental annual NOI by Q4 2026 from projects 93% leased or negotiating. Alexandria Real Estate Equities (ARE - Free Report) shares have gained 10.9% over the past month compared with the industry's growth of 2.4%.

The company owns a premium portfolio of life science campuses in high-barrier U.S. innovation clusters. Demand is uneven, but leasing to established tenants and its Megacampus platform supports cash flow durability. The balance sheet remains liquid and mostly fixed-rate, which provides financial flexibility.

This real estate investment trust (REIT) carries a Zacks Rank #3 (Hold). The Zacks Consensus Estimate for its 2026 FFO per share is now pegged at $6.40.

Image Source: Zacks Investment Research

Factors Behind ARE’s Share Price RiseAlexandria’s primary emphasis is on the development of Class A/A+ properties strategically located within AAA innovation cluster regions. Alexandria’s Megacampus platform represented 78% of annual rental revenues in effect as of March 31, 2026, keeping the portfolio concentrated in the deepest U.S. life science clusters. Leasing volume in first-quarter 2026 was 647,356 RSF, and 72% of activity came from the existing tenant base, reflecting tenant stickiness in mission-critical lab space.

The company’s Class A/A+ properties in AAA locations are experiencing high demand, aiding occupancy levels and rent growth. As of March 31, 2026, investment-grade or publicly traded large-cap tenants accounted for 55% of annual rental revenues in effect, and the weighted-average remaining lease term was 7.5 years for all tenants and 9.9 years for the top 20. Alexandria reported 97% of leases contain annual rent escalations, supporting contractual revenue growth over time.

Alexandria’s near-term development and redevelopment deliveries are positioned to add incremental NOI as initial free rent burns off and space is placed into service. Management’s pipeline disclosures indicate projects expected to be placed into service from second-quarter 2026 through fourth-quarter 2026 are 93% leased or negotiating, supporting its expectation for $92 million of incremental annual NOI by fourth-quarter 2026.

Alexandria has adequate financial flexibility to cushion and enhance its market position. The company had $4.17 billion of liquidity as of the end of the first quarter of 2026 and maintained its fourth-quarter 2026 annualized leverage target of 5.6X to 6.2X net debt and preferred stock to adjusted EBITDA. The company’s 96.4% of debt was fixed-rate, with a 10.0-year weighted-average remaining term. ARE enjoys credit ratings of Baa1 and BBB+ from Moody’s and S&P Global Ratings, respectively. This renders access to the debt market at favorable costs, positioning it well to bank on growth opportunities.

Risks Likely to Affect ARE’s Positive TrendRisks for Alexandria include lower occupancy after expirations, negative renewal spreads and muted biotech demand. Additional pressure comes from development timing risk and higher interest costs.

Stocks to ConsiderSome better-ranked stocks from the broader REIT sector are Vornado Realty Trust (VNO - Free Report) and W.P. Carey (WPC - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for VNO’s 2026 FFO per share has been revised upward by a cent to $2.34 over the past month.

The consensus estimate for WPC’s 2026 FFO per share has been raised northward 1.3% over the past two months to $5.28.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO) — a widely used metric to gauge the performance of REITs.

Omega Healthcare Investors is downgraded from bullish to neutral as valuation now reflects its recovery and growth prospects. OHI's dividend is well covered, with payout ratios at 82% of AFFO and 86% of FAD, and management hints at a possible raise in 2027. Active portfolio management, capital recycling, and a strategic pivot toward RIDEA and senior housing are driving operational improvements and future growth potential.

-

BOSTON--(BUSINESS WIRE)--BXP, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that its Board of Directors declared a regular quarterly cash dividend of $0.70 per share of common stock for the period April 1, 2026 to June 30, 2026, payable on July 31, 2026 to shareholders of record as of the close of business on June 30, 2026.

BXP, Inc. (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 55 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). As of March 31, 2026, including properties owned by unconsolidated joint ventures, BXP’s portfolio totaled 50.4 million square feet and 164 properties, including six properties under construction/redevelopment. For more information about BXP, please visit our website or follow us on LinkedIn or Instagram.

More News From BXP, Inc.

Back to Newsroom

Investors with an interest in Internet - Software stocks have likely encountered both Digital Turbine (APPS) and Autodesk (ADSK). But which of these two companies is the best option for those looking for undervalued stocks?

Accenture guided investors to expect 3-5% full-year revenue growth while undisclosed headwinds were already pressuring the business -- then cut the outlook and watched the stock fall more than 18%

, /PRNewswire/ -- Accenture (NYSE: ACN) shareholders lost approximately 18.5% of their investment value today after the company slashed its fiscal year 2026 revenue growth forecast to 3-4%, down from the 3-5% range it had previously provided. Those who lost money on ACN shares are encouraged to submit their information immediately. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (888) SueWallSt.

Accenture's prior guidance, issued during its fiscal Q2 earnings report on March 19, 2026, projected 3-5% revenue growth for full-year fiscal 2026, uplifted from Q1's previous 2-5% target. Today's Q3 results narrowed that range by cutting the upper bound, and the stock recorded its largest single-day percentage decline on record. The Q3 revenue figure of $18.7 billion came in below analyst expectations of $18.78 billion.

Morgan Stanley had downgraded Accenture to Hold on June 16 and cut its price target from $240 to $177, citing concerns that anticipated AI spending rationalization had "not played out." Two days later, the company's own guidance revision confirmed that the growth trajectory management had projected just three months earlier was no longer achievable.

Shareholders who purchased ACN and suffered losses may click here to discuss their legal rights. You may also reach Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.

ABOUT THE FIRM -- For over two decades, SueWallSt has represented shareholders in securities investigations and actions. Ranked in ISS Top 50 for seven consecutive years.

Frequently Asked Questions About the ACN Investigation

Q: Who is conducting the ACN investigation?A: SueWallSt is investigating potential securities law concerns on behalf of investors who purchased ACN securities and suffered financial losses. The firm is nationally recognized, ranked in the ISS Top 50 for seven consecutive years, and has recovered hundreds of millions of dollars for aggrieved investors.

Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Accenture made materially false or misleading statements regarding its full-year fiscal 2026 revenue growth outlook. When the company revised its guidance downward on June 18, 2026, the stock price declined sharply.

Q: What do ACN investors need to do right now?A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt for a free, no-obligation evaluation at [email protected] or (888) SueWallSt. No immediate action is required to remain eligible to participate in the investigation.

Q: What if I already sold my ACN shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought ACN and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate?A: Nothing. Securities investigations are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: Do I need to go to court or give testimony?A: No. Participating in the investigation does not require court appearances or depositions.

Q: What if I live outside the United States?A: U.S. securities investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

CONTACT:\
SueWallSt\
Joseph E. Levi, Esq.\
Ed Korsinsky, Esq.\
33 Whitehall Street, 27th Floor\
New York, NY 10004\
[email protected]\
Tel: (888) SueWallSt\
Fax: (212) 363-7171

SOURCE SueWallSt.com

India's Nifty IT ​index slumped 5.6% on Friday after industry ‌bellwether Accenture forecast quarterly sales below Wall Street view and lowered the upper end of its annual ​revenue outlook due to weakness in its ​Middle East business.

Stocks of major Indian information technology companies fell as much as 7% on Friday after global professional service giant Accenture lowered its revenue guidance, souring sentiment toward the sector.

Shares of India's largest IT company, Tata Consultancy Services, were down over 5%. Infosys dropped more than 7% while Tech Mahindra declined over 4%. The benchmark Nifty IT Index slid more than 5%.

Accenture on Thursday cut its revenue growth guidance for the financial year ending August 2026 to between 3% and 4% from its previous forecast of 4% to 5%.

"On the revenue side, we missed revenue consensus by $90 million, and we had a $100 million impact from the Middle East," Accenture CEO Julie Sweet told CNBC's Squawk on the Street on Thursday, discussing the company's third-quarter results.

watch now

Global brokerage Citi said Thursday it remains cautious on the Indian IT sector, noting that the Nifty IT index trades around 16 times one-year forward earnings, while Accenture trades at 10 times.

"We have been cautious given AI disruption, increased competitive intensity, GCC trends, etc.; the macro uncertainty increases the challenges near term," as per Citi's note.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Accenture plc (“Accenture” or “the Company”) (NYSE: ACN) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Accenture lowered its guidance for full-year sales, causing shares to tumble 18% on June 18, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260620471237/en/

Rapid delivery demonstrates how CEO-led business process reengineering can accelerate data driven management

TOKYO--(BUSINESS WIRE)--INFRONEER Holdings Inc. ("INFRONEER HD"), in collaboration with Accenture (NYSE: ACN) and SAP Japan, today announced that it has built a new financial data and insights platform—the digital core of its data driven management—in just three months. This rapid delivery was made possible by CEO-led business process reengineering.

The new platform is the first deliverable of a broader project to build a data-driven, next generation digital core that seamlessly connects management information end-to-end—from project-level cost management to group-wide financial accounting—enabling faster, more sophisticated decision-making across the group. This project marks a key step in INFRONEER HD's transformation toward becoming an integrated infrastructure service company spanning the full lifecycle of infrastructure, moving beyond the traditional contracting-centered model. Responding to industry-wide challenges such as aging infrastructure, labor shortages, and slow digitalization, and amid group expansion through M&A, INFRONEER HD has advanced its group management capabilities by consolidating and visualizing critical management data with Accenture. INFRONEER Strategy & Innovation*, a joint venture established by the two companies in April 2025 accelerated this work.

For this project, SAP® Cloud ERP was implemented for the financial accounting domain at the core of group management. Achieving one of the fastest implementations of its kind in Japan reflects INFRONEER HD's long-standing, management led business reform approach—working closely with its operating companies to deeply understand frontline realities and business specifics. The achievement was further driven by the new implementation approach announced by Accenture and SAP in April—designed to rapidly deploy SAP Cloud ERP as a foundation for AI driven value creation—and by a joint dedicated team that led delivery.

Looking ahead, INFRONEER HD and Accenture will extend this approach to additional functions such as procurement and cost management, while advancing AI-powered analytics and predictive insights to elevate the quality and speed of decision-making across the group. In the longer term, INFRONEER HD aims to evolve these initiatives into a model that can be scaled across the infrastructure and construction industry, contributing to industry-wide productivity and the resolution of societal challenges surrounding infrastructure.

Kazunari Kibe, Representative Executive Officer and President, INFRONEER Holdings Inc., said, "The most important insight from this project is that building core enterprise systems should be treated not as an operational project, but as a management driven initiative. These projects often become prolonged because development begins before management has defined what data it needs to see and how it will use that data to make decisions—questions only management can answer. At INFRONEER HD, we have long practiced data driven management and refined our management framework together with Accenture. That foundation enabled us to deploy our financial accounting system in just three months and begin expanding into other business areas—rather than years such projects typically require. Going forward, we plan to extend this approach into other functions and across the entire group and position management led, data driven transformation as a catalyst for innovation in the infrastructure and construction industry."

Dai Hamaoka, Representative Director and President Japan Country Managing Director, Accenture, said, "Through its Reinvention Services, Accenture helps clients achieve rapid transformation by integrating management and performance improvement, business and operational reform, core system modernization, data and AI, ecosystem collaboration, and operations outsourcing into a single, connected effort. Our work with INFRONEER HD is Reinvention Services in action: We combined data- and AI-powered business reform with operational efficiency and end-to-end transformation from the boardroom to the front line to bring core enterprise systems live in just three months. This is a best-case outcome enabled by specific preconditions—executive engagement, prior business reform, organizational culture, and industry and process context—and while it may not apply to every client, this approach can reliably reduce both implementation timelines and investment. As AI becomes central to enterprise management, the ability to deliver this kind of implementation speed is more critical than ever to sharpening decision-making, raising productivity, and strengthening competitiveness."

Yoshiro Horikawa, President & Representative Director, SAP Japan, said, "This initiative by INFRONEER HD represents a concrete outcome of the collaboration program between SAP Japan and Accenture to rapidly establish SAP Cloud ERP as a foundation for AI driven value creation. Brought live in just three months, this advanced project serves as a flagship SAP Cloud ERP initiative in Japan's construction industry. By combining customers' strong commitment to management transformation and deep understanding of Japanese business operations with SAP's global standardization expertise and advanced technologies, SAP Japan will continue supporting customers in advancing operations that underpin social infrastructure."

* For more information about INFRONEER Strategy & Innovation, please visit https://www.isi.infroneer.com/.

About INFRONEER Holdings
INFRONEER Holdings (“INFRONEER HD”) was established in 2021 with Maeda Corporation, Maeda Road Construction, and Maeda Seisakusho as its core operating companies. Building on the engineering capabilities cultivated over many years across civil engineering, building construction, paving, and machinery, INFRONEER HD is an integrated infrastructure services company that manages the entire lifecycle of infrastructure—from planning and proposal, through design and construction, to operation and maintenance.

Since its founding, INFRONEER HD has steadily expanded its business domains—welcoming Japan Wind Development and Sumitomo Mitsui Construction into the group, with Swing Corporation scheduled to join in July 2026—extending its reach into areas including renewable energy and water infrastructure.

In response to societal challenges such as aging infrastructure and population decline, INFRONEER HD is driving a business model transformation built on the concept of "contracting and de-construction." By proactively assuming project risk and covering the entire value chain from investment, development and construction to operation and maintenance in an integrated manner, the company contributes to the realization of sustainable infrastructure and the creation of new value.

For more information about INFRONEER Holdings, please visit https://www.infroneer.com/en/.

About Accenture
Accenture helps the world’s leading enterprises reinvent by building their digital core and unleashing the power of AI to create value at speed for organizations across industries. Our strategy is to be the reinvention partner of choice for our clients and lead in the safe, widespread adoption of AI, and to be the most client-focused, AI-enabled, great place to work in the world. We bring together the talent of our approximately 799,000 people with proprietary assets and platforms, deep process and industry expertise, and leading ecosystem relationships to deliver end-to-end solutions and measurable outcomes at scale. Through our Reinvention Services, we offer broad expertise across Cybersecurity, Digital Core, Finance, Industry and Enterprise, Song, Supply Chain and Engineering, and Talent, with advanced capabilities in AI and Data, Industry and Process, and Technology. We serve approximately 9,000 clients and generated approximately $70 billion in FY25 revenue. Visit us at accenture.com.

About SAP Japan
SAP Japan was established in 1992 as the Japanese subsidiary of SAP SE. As a global leader in enterprise applications and business AI, SAP (NYSE:SAP) stands at the nexus of business and technology. For over 50 years, organizations have trusted SAP to bring out their best by uniting business-critical operations spanning finance, procurement, HR, supply chain, and customer experience. For more information, visit http://www.sap.com/japan.

This document contains forward-looking statements, which are predictions, projections, or other statements about future events. These statements are based on current expectations, forecasts, and assumptions that are subject to risks and uncertainties that could cause actual results and outcomes to materially differ. Additional information regarding these risks and uncertainties may be found in our filings with the Securities and Exchange Commission, including but not limited to the risk factors section of SAP’s 2025 Annual Report on Form 20-F.

Copyright © 2026 Accenture. All rights reserved. Accenture and its logo are trademarks of Accenture.

© 2026 SAP SE. All rights reserved. SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

Technology

A Bad Bet on ‘Durability’: The Crux of Accenture’s Stunning Stock Slide

In this article

Accenture stock was downgraded to Hold from Buy with a $150 price target, down from $258, at TD Cowen. (Dreamstime)

In the fallout of Accenture dismal disappointing report, Wall Street continues to lower expectations.